[Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride]
Standard
[Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride]. / Wolf, Karsten; Veismann, Stefan; Knecht, Guntram; Naber, Dieter.
In: PSYCHIAT PRAX, Vol. 33, No. 1, 1, 2006, p. 42-44.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride]
AU - Wolf, Karsten
AU - Veismann, Stefan
AU - Knecht, Guntram
AU - Naber, Dieter
PY - 2006
Y1 - 2006
N2 - BACKGROUND: Therapy resistant, severe residual schizophrenia poses major challenges for the psychiatric pharmacological treatment. METHOD: We report about a 44-year old schizophrenic male who has been detained in a closed forensic ward for 10 years, following a conviction in one manslaughter case. Despite various pharmacological treatment efforts severe residual schizophrenia remained. RESULT: Adding Amisulpride to the ongoing treatment with Olanzapine achieved a noticeable improvement of symptoms, resulting in the possibility of relaxing imprisonment conditions. CONCLUSION: A combination of Amisulpride and Olanzapine seems to be effective in treating severe residual schizophrenia.
AB - BACKGROUND: Therapy resistant, severe residual schizophrenia poses major challenges for the psychiatric pharmacological treatment. METHOD: We report about a 44-year old schizophrenic male who has been detained in a closed forensic ward for 10 years, following a conviction in one manslaughter case. Despite various pharmacological treatment efforts severe residual schizophrenia remained. RESULT: Adding Amisulpride to the ongoing treatment with Olanzapine achieved a noticeable improvement of symptoms, resulting in the possibility of relaxing imprisonment conditions. CONCLUSION: A combination of Amisulpride and Olanzapine seems to be effective in treating severe residual schizophrenia.
M3 - SCORING: Zeitschriftenaufsatz
VL - 33
SP - 42
EP - 44
JO - PSYCHIAT PRAX
JF - PSYCHIAT PRAX
SN - 0303-4259
IS - 1
M1 - 1
ER -